Administration - Core C

管理 - 核心 C

• 批准号: 10245090
• 负责人: Tracy T Batchelor
• 金额: $ 26.05万
• 依托单位: BRIGHAM AND WOMEN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-09-19 至 2024-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10245090
• 关键词: Academic Medical Centers; Administrator; Adult; Adult Glioma; Age-Years; Cancer Center; Cancer Etiology; Cessation of life; Childhood Glioma; Clinical; Clinical Trials; Collaborations; Communication; Communication Programs; Female; Foundations; Funding; Gender; Glioma; Grant; Human Resources; Image; Infrastructure; Institution; Leadership; Minority; Monitor; Persons; Positioning Attribute; Preparation; Primary Brain Neoplasms; Protocols documentation; Research; Research Design; Research Personnel; Role; Series; Specialized Program of Research Excellence; Structure; Supervision; Translational Research; Underrepresented Minority; Woman; Work; clinical imaging; design; experience; imaging scientist; imaging study; improved; meetings; member; multidisciplinary; patient population; pediatric patients; programs; ranpirnase; standard of care; success; targeted treatment

This Specialized Program of Research Excellence (SPORE) grant is intended to support multi-project, interdisciplinary and multi-institutional translational research in glioma. The governance structure of this Dana- Farber/Harvard Cancer Center (DF/HCC) SPORE grant provides the foundation for the implementation, execution and ultimate success of all projects and cores. The Administration Core serves as the “hub” for this governance structure and aims to achieve a number of specific objectives as defined below. We will execute a plan that provides experienced, centralized program leadership and administration. The Glioma SPORE Director and Co-Director are senior administrators, institutional leaders, and researchers who have worked together on the current funding period for this SPORE and on prior DF/HCC initiatives and, consequently, provide consistent, strong, complementary leadership for the grant. The trans-institutional administrative team consists of senior personnel at DF/HCC institutions who have worked together effectively in the current funding period of this grant. We will expand our management to an external, funded component (Project Four) of the SPORE at Stanford University Medical Center and to both adult and pediatric patient populations. We maintain two senior clinical and imaging scientists in the Administration Core to supervise Glioma SPOREspecific clinical trials and Glioma SPORE-specific imaging studies, respectively, and to enable this Glioma SPORE to capitalize on existing DF/HCC P30 Cores to support these types of studies. We have established and utilized an effective internal and external committee structure to provide multidisciplinary expertise, advice and oversight of the program. Each of the committees consists of collaborative, complementary members who have worked together in the current funding period of this SPORE or on prior projects. A series of regular Glioma SPORE meetings involving both administrative and scientific SPORE personnel will continue to facilitate close collaboration, troubleshooting, and monitoring of the SPORE program. We will continue and expand an effective internal and external communications program, which includes a Glioma SPORE-specific component. An established and extensive DF/HCC communications infrastructure is utilized to promote open, regular, trans-institutional communication regarding SPORE opportunities and activities. We will reinforce an active SPORE program to enhance participation by underrepresented minorities and women.

这项专门的卓越研究计划(SPORT)赠款旨在支持多个项目， 神经胶质瘤的跨学科和多机构翻译研究。这个DANA的治理结构- 法伯/哈佛癌症中心(DF/HCC)孢子赠款为实施提供了基础， 所有项目和核心的执行和最终成功。管理核心是这方面的“枢纽” 治理结构，目标是实现以下定义的若干具体目标。我们将执行一个 提供经验丰富的集中化计划领导和管理的计划。胶质瘤孢子 主任和联席主任是高级管理人员、机构领导人和研究人员，他们曾 共同讨论这一孢子的当前资助期和以前的DF/HCC倡议，因此， 为赠款提供始终如一、强有力、互补性的领导。跨机构的行政团队 由在当前资金中有效合作的DF/HCC机构的高级人员组成 这项资助的期限。我们将把我们的管理扩展到外部资助的部分(项目四) 孢子在斯坦福大学医学中心和成人和儿科患者群体。我们 在行政核心中保留两名高级临床和影像科学家，以监督特定的胶质瘤SPORE 临床试验和胶质瘤孢子特异性成像研究，并使这种胶质瘤 孢子利用现有的DF/HCC P30核心来支持这些类型的研究。我们已经确立了 并利用有效的内部和外部委员会结构提供多学科的专业知识、建议 以及对该项目的监督。每个委员会都由协作、互补的成员组成，这些成员 在该孢子的当前资助期或以前的项目中合作过。一系列常规的 包括行政和科学孢子人员在内的胶质瘤孢子会议将继续 促进孢子项目的密切协作、故障排除和监控。我们将继续并 扩展有效的内部和外部沟通计划，其中包括针对Glioma孢子的 组件。利用已建立和广泛的DF/CC通信基础设施来促进开放、 关于孢子机会和活动的定期、跨机构沟通。我们将加强对 积极的孢子方案，以加强代表不足的少数群体和妇女的参与。